Physician profile
Deepa Halaharvi
NPI 1043485253
$16,639.80
in general payments reported to CMS, 2019-2025
15 companies · $173 in 2025
The $173 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $333 · 2020: $92.35 · 2021: $506 · 2022: $3,131 · 2023: $4,377 · 2024: $8,027 · 2025: $173.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $11K · Food and Beverage: $1,227 · Travel and Lodging: $775.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $10,575.00 |
| Food and Beverage | $1,227.11 |
| Travel and Lodging | $775.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic INC | $11,740.09 | 2021-2024 | Biozorb, Trident Specimen Radiography System, Localizer |
| Novartis Pharmaceuticals Corporation | $1,648.00 | 2024-2025 | |
| Stryker Corporation | $1,369.18 | 2019-2022 | |
| Endomagnetics LTD | $729.23 | 2023-2024 | Magtrace, Magseed |
| Dilon Technologies, INC. | $217.75 | 2023 | Hemoblast Bellows |
| Integra Lifesciences Corporation | $123.09 | 2021 | |
| Genzyme Corporation | $120.79 | 2022 | |
| Merck Sharp & Dohme LLC | $117.12 | 2022 | |
| Solventum Corporation | $117.09 | 2024 | Prevena |
| Medical Device Business Services, INC. | $111.68 | 2019 | |
| Innovation Technologies INC | $100.00 | 2025 | Irrisept |
| Axogen | $81.44 | 2022 | |
| Conmed Corporation | $76.43 | 2020 | |
| Genentech USA, INC. | $71.99 | 2019 | |
| Covidien LP | $15.92 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deepa Halaharvi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.